Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05117203
Other study ID # ETICA-ULE-009-2020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 11, 2021
Est. completion date June 15, 2022

Study information

Verified date October 2022
Source Universidad de León
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the immediate effects on the abdominal musculature, assessed by ultrasound (RUSI), due to the application of electrostimulation using whole body electrostimulation together with physical exercise in healthy people and to compare with the application of local EMS in the abdominal area and the same physical exercise session. The same intervention is carried out for the control group as the WB-EMS group but simulated.


Description:

Evaluation of the immediate changes in the thickness of the abdominal muscles (Transversus abdominis, Internal and External Oblique and Rectus abdominis) and in the Interrectus distance after the physical exercise session together with whole body electrostimulation or local electrostimulation assessed by ultrasound (RUSI) in healthy people.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date June 15, 2022
Est. primary completion date May 10, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Healthy participants - Good medical history without injury or chest pain in the past year - No surgeries in the previous year. Exclusion Criteria: - Upper body mass index 30 Kg/m2 - Level of professional or elite sports activity - Hyperventilation / hypercapnia and score above 23 points on the Nijmegen questionnaire - Present any contraindication regarding the WB-EMS/EMS - Viral o bacterial infections - Arterial circulatory disorders, advanced arteriosclerosis - Women during their menstrual period - Type I diabetes, hemophilia, bruises, bleeding, cognitive deficit, fibromyalgia, congenital diseases with muscle-skeletal alterations at the level of the back and lower extremities, scoliosis, protrusion or disc herniation, medication consumption, abdominal surgeries (scars or keloids), abdominal muscle injury. - Presence of chronic low back, hip or thigh pain

Study Design


Related Conditions & MeSH terms


Intervention

Device:
WB-EMS (Whole body electrostimulation)
Application of physical exercise and electrical stimulation on the abdominal muscles through the WB-EMS during 20 minutes training session with specific exercise (CORE)
EMS
Application of physical exercise and electrical stimulation on the abdominal muscles through the EMS during 20 minutes training session with specific exercise (CORE)
WB-EMS off
Application of physical exercise without electrical stimulation on the abdominal muscles through the WB-EMS off during a 20 minutes training session with specific exercise (CORE).

Locations

Country Name City State
Spain Universidad de León Ponferrada León

Sponsors (1)

Lead Sponsor Collaborator
Universidad de León

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of muscle thickness of the abdominal muscles by ultrasound through the technique "Rehabilitative Ultrasound Imaging" (RUSI). Measure muscle thickness before and after exercise with electrostimulation One day
Primary Measurement of the Distance between Rectus abdominis using ultrasound (RUSI) Measure the distance between Rectus abdominis before and after exercise with electrostimulation One day
Secondary International physical activity questionnaire (IPAQ) Classification according to low, moderate or high physical activity level One day
Secondary Nijgemen questionnaire A level of respiratory distress equal to or higher than 23 points is an exclusion criterion for exclusion from the study One day
Secondary Body height Body height in meters One day
Secondary Body weight Body weight in kilograms One day
Secondary Body mass index Calculation of body mass index in Kg/m2 according to Queletet method One day
Secondary Heart frequency Measurement of the heart rate (beats per minute) One day
Secondary Blood pressure Measurement of systolic and diastolic blood pressure using a sphygmomanometer One day
Secondary body temperature Measurement of body temperature in Celsius with a digital thermometer one day
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1